A randomized controlled trial was conducted to compare
January 2nd, 2018
A randomized controlled trial was conducted to compare men receiving a treatment regimen of Omega-X vs. a treatment regimen of Delta-M for treatment of hepatitis C. Overall, 300 men participated in this study; 150 were randomized to each treatment. Twelve weeks after treatment, the participants were tested to see if their infection has improved or gotten worse (an outcome called virologic failure). The results of this study are below.Omega-XDelta-MTotalVirologic failure314172No virologic failure119109228Total1501503003a. Calculate by hand the expected cell counts in each